Literature DB >> 35979411

Adapting a family-involved intervention to increase initiation and completion of evidenced-based psychotherapy for posttraumatic stress disorder.

Megan Shepherd-Banigan1,2,3, Stephanie Y Wells1, Margaret Falkovic1,2, Princess E Ackland4,5, Cindy Swinkels1, Eric Dedert1,6, Rachel Ruffin1, Courtney H Van Houtven1,2,3, Patrick S Calhoun1,6, David Edelman1,7, Hollis J Weidenbacher1, Abigail Shapiro1, Shirley Glynn8.   

Abstract

Posttraumatic stress disorder (PTSD) is disabling condition among United States Veterans. Training programs for evidenced-based therapies have been rolled out nationally in the Veterans Health Administration (VHA), but provider adoption of these treatments is limited and rates of Veteran dropout are high. Increasing support for mental health therapy within the Veteran's social network would improve treatment engagement. We discuss the adaptation of Recovery-Oriented Decisions for Relatives' Support (REORDER)-a family-based intervention for individuals with serious mental illness- to create Family Support in Mental Health Recovery (FAMILIAR), an intervention that seeks to strengthen support partners' abilities to help Veterans engage in therapy. Our goal was to apply modifications to meet the needs of Veterans with PTSD and their support partners. We used input from Veterans, support partners, clinicians and VA system leaders to inform the modifications. Then, a multi-disciplinary intervention development team met to determine which modifications would be applied and how. We used the domains from the Framework for Adaptations and Modification (FRAME) to systematically track and describe modifications. Adaptations made to REORDER included changes in content, structure, and delivery format. The resulting intervention, FAMILIAR, was a 3-4 session intervention beginning prior to EBP initiation and continuing through sessions 3, 4 or 5 of the EBP. Sessions were designed for maximum flexibility and could be offered either in-person or virtually, and sessions involve interactions between the interventionist with the Veteran and support partner alone and together. We learned the importance of including diverse stakeholder perspectives to develop a comprehensive understanding of the needs of the target population and the health system. While feasibility and effectiveness testing is needed, we applied a proactive adaptation approach that we anticipate will make FAMILIAR successful in addressing patient, clinical, and system considerations of a family approach to increase Veteran engagement in PTSD treatment.

Entities:  

Keywords:  Framework for Adaptations and Modification (FRAME); Veterans; intervention adaptation; posttraumatic stress disorder (PTSD); psychotherapy; social support

Year:  2022        PMID: 35979411      PMCID: PMC9376943          DOI: 10.1016/j.ssmmh.2022.100114

Source DB:  PubMed          Journal:  SSM Ment Health        ISSN: 2666-5603


  41 in total

1.  The impact of PTSD on veterans' family relationships: an interpretative phenomenological inquiry.

Authors:  Susan L Ray; Meredith Vanstone
Journal:  Int J Nurs Stud       Date:  2009-02-07       Impact factor: 5.837

2.  Predictors of completion of exposure therapy in OEF/OIF veterans with posttraumatic stress disorder.

Authors:  Daniel F Gros; Matthew Price; Erica K Yuen; Ron Acierno
Journal:  Depress Anxiety       Date:  2013-10-21       Impact factor: 6.505

3.  The influence of trauma and patient characteristics on provider burnout in VA post-traumatic stress disorder specialty programmes.

Authors:  Hector A Garcia; Cindy A McGeary; Erin P Finley; Donald D McGeary; Norma S Ketchum; Alan L Peterson
Journal:  Psychol Psychother       Date:  2015-01-21       Impact factor: 3.915

4.  Predisposing, enabling, and need factors as predictors of low and high psychotherapy utilization in veterans.

Authors:  Natalie E Hundt; Terri L Barrera; Juliette M Mott; Joseph Mignogna; Hong-Jen Yu; Shubhada Sansgiry; Melinda A Stanley; Jeffrey A Cully
Journal:  Psychol Serv       Date:  2014-05-19

5.  Impact of treatment beliefs and social network encouragement on initiation of care by VA service users with PTSD.

Authors:  Michele R Spoont; David B Nelson; Maureen Murdoch; Thomas Rector; Nina A Sayer; Sean Nugent; Joseph Westermeyer
Journal:  Psychiatr Serv       Date:  2014-05-01       Impact factor: 3.084

6.  A non-inferiority trial of Prolonged Exposure for posttraumatic stress disorder: In person versus home-based telehealth.

Authors:  Ron Acierno; Rebecca Knapp; Peter Tuerk; Amanda K Gilmore; Carl Lejuez; Kenneth Ruggiero; Wendy Muzzy; Leonard Egede; Melba A Hernandez-Tejada; Edna B Foa
Journal:  Behav Res Ther       Date:  2016-11-22

7.  Sticking it out in trauma-focused treatment for PTSD: It takes a village.

Authors:  Laura A Meis; Siamak Noorbaloochi; Emily M Hagel Campbell; Christopher R Erbes; Melissa A Polusny; Tina L Velasquez; Ann Bangerter; Andrea Cutting; Afsoon Eftekhari; Craig S Rosen; Peter W Tuerk; Lori B Burmeister; Michele R Spoont
Journal:  J Consult Clin Psychol       Date:  2019-03

8.  Going direct to the consumer: Examining treatment preferences for veterans with insomnia, PTSD, and depression.

Authors:  Cassidy A Gutner; Eric R Pedersen; Sean P A Drummond
Journal:  Psychiatry Res       Date:  2018-03-30       Impact factor: 3.222

9.  Effect of cognitive-behavioral couple therapy for PTSD: a randomized controlled trial.

Authors:  Candice M Monson; Steffany J Fredman; Alexandra Macdonald; Nicole D Pukay-Martin; Patricia A Resick; Paula P Schnurr
Journal:  JAMA       Date:  2012-08-15       Impact factor: 56.272

10.  Can families help veterans get more from PTSD treatment? A randomized clinical trial examining Prolonged Exposure with and without family involvement.

Authors:  Laura A Meis; Shirley M Glynn; Michele R Spoont; Shannon M Kehle-Forbes; David Nelson; Carl E Isenhart; Afsoon Eftekhari; Princess E Ackland; Erin B Linden; Robert J Orazem; Andrea Cutting; Emily M Hagel Campbell; Millie C Astin; Katherine E Porter; Erin Smith; Christopher D Chuick; Kristen E Lamp; Tessa C Vuper; Taylor A Oakley; Lila B Khan; Sally K Keckeisen; Melissa A Polusny
Journal:  Trials       Date:  2022-03-30       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.